Insider selling
Traded Apr 14 · filed 1 day laterNot reported under a pre-arranged trading plan
A Genprex director sold $12 of Genprex shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Apr 14, 2026 · Filed Apr 15, 2026
A Genprex director sold $10 of Genprex shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$10
Shares × reported transaction price
Closed at $26.62 on Apr 14, 2026, 5% above its 52-week low and 97% below its high, after a 39% drop over the previous 30 trading days
52-week range $25.30 (Apr 10, 2026) to $924.00 (Oct 15, 2025), 0% of the way up, from 250 adjusted closes. 30 trading days earlier: $43.78 on Mar 2, 2026. Describes the past only, not a forecast
RSI 25, 82% under its 200-day average, 36% under its 50-day average, 97% below the 52-week high, 20-day volatility 72% a year, against the S&P 500: −45 points over 1 month, −53 points over 3 months, −95 points over 6 months
From the adjusted closes up to Apr 14, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −21.5% | +1.0% | −22.5% |
| 30 days | −38.1% | +5.3% | −43.4% |
| 90 days | −62.2% | +7.6% | −69.8% |
| 180 days | −91.2% | +10.9% | −102.1% |
Past results only. Not a forecast.
Insider selling
Traded Apr 14 · filed 1 day laterNot reported under a pre-arranged trading plan
A Genprex director sold $12 of Genprex shares. The filing does not indicate a pre-arranged trading plan.
Insider filing
Traded Feb 27 · filed the same day
Routine share withholding; mechanical by default.
Insider filing
Traded Feb 27 · filed the same day
Routine share withholding; mechanical by default.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.